BP pill recall exposes drug safety gaps

Authorities have recalled BP pills from the market due to safety concerns, exposing gaps in drug regulation. The recall affects patients relying on the medication for blood pressure management. Officials urge consumers to return affected batches and seek alternatives. This incident highlights the need for stricter quality control and monitoring of pharmaceutical products.